Table 3.
Crude rates of fatal (or life-threatening) bleeding from phase III trials comparing a TSOAC to standard therapy (usually warfarin)
View large
Crude rates of fatal (or life-threatening) bleeding from phase III trials comparing a TSOAC to standard therapy (usually warfarin)

HR indicates hazard ratio; CI, confidence interval; and N/R not reported.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal